Gemina Laboratories Ltd. (TSE:GLAB) has released an update.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Gemina Laboratories Ltd. has successfully raised $435,000 through the exercise of common share purchase warrants and has also settled a $40,000 debt with lenders by issuing 100,000 common shares at a discounted price. The company is known for its innovative biosensor and diagnostic technology, which is currently being developed for rapid testing of various pathogens, including COVID-19 and influenza.
For further insights into TSE:GLAB stock, check out TipRanks’ Stock Analysis page.